17 results for author:"Gires O." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| MMP7 is a target of the tumour-associated antigen EpCAM. Denzel S., Mack B., Eggert C., Massoner P., Stocklein N., Kemming D., Harreus U., Gires O. Int J Exp Pathol 93:341-353(2012) · Mapped (5) |
| CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling. Hampel F., Ehrenberg S., Hojer C., Draeseke A., Marschall-Schroter G., Kuhn R., Mack B., Gires O., Vahl C.J., Schmidt-Supprian M. et al. Blood 118:6321-6331(2011) · Mapped (9) |
| Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110. Petsch S., Gires O., Ruttinger D., Denzel S., Lippold S., Baeuerle P.A., Wolf A. MAbs 3:31-37(2011) · Mapped (1) |
| Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Hartmannsberger D., Mack B., Eggert C., Denzel S., Stepp H., Betz C.S., Gires O. Cancer Lett. 300:20-29(2011) · Mapped (8) |
| Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Rauch J., O'Neill E., Mack B., Matthias C., Munz M., Kolch W., Gires O. Cancer Res. 70:1679-1688(2010) · Mapped (11) |
| Initial activation of EpCAM cleavage via cell-to-cell contact. Denzel S., Maetzel D., Mack B., Eggert C., Barr G., Gires O. BMC Cancer 9:402-402(2009) · Mapped (1) |
| The emerging role of EpCAM in cancer and stem cell signaling. Munz M., Baeuerle P.A., Gires O. Cancer Res. 69:5627-5629(2009) · Mapped (1) |
| Nuclear signalling by tumour-associated antigen EpCAM. Maetzel D., Denzel S., Mack B., Canis M., Went P., Benk M., Kieu C., Papior P., Baeuerle P.A., Munz M. et al. Nat. Cell Biol. 11:162-171(2009) · Mapped (1) |
| On the abundance of EpCAM on cancer stem cells. Gires O., Klein C.A., Baeuerle P.A. Nat. Rev. Cancer 9:143; author reply 2009:143-143(2009) · Mapped (1) |
| CD44s and CD44v6 expression in head and neck epithelia. Mack B., Gires O. PLoS ONE 3:e3360-e3360(2008) · Mapped (6) |
| Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. Munz M., Fellinger K., Hofmann T., Schmitt B., Gires O. Front. Biosci. 13:5195-5201(2008) · UniProtKB (1) |
| Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation. Ahlemann M., Zeidler R., Lang S., Mack B., Munz M., Gires O. Mol. Carcinog. 45:957-967(2006) · Mapped (10) |
| Molecular characterization of the tumor-associated antigen AAA-TOB3. Schaffrik M., Mack B., Matthias C., Rauch J., Gires O. Cell. Mol. Life Sci. 63:2162-2174(2006) · UniProtKB (1) |
| The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Muenz M., Zeidler R., Gires O. Cancer Lett. 225:151-157(2005) · UniProtKB (1) |
| The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Muenz M., Kieu C., Mack B., Schmitt B., Zeidler R., Gires O. Oncogene 23:5748-5758(2004) · UniProtKB (1) |
| Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter. Gires O., Eskofier S., Lang S., Zeidler R., Munz M. Anticancer Res. 23:3255-3261(2003) · Mapped (1) |
| The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1. Baumann M., Gires O., Kolch W., Mischak H., Zeidler R., Pich D., Hammerschmidt W. Eur. J. Biochem. 267:3891-3901(2000) · UniProtKB (2) |